Non-Opioid Pain Treatment Market Opportunities Are Emerging Beyond Traditional Growth Areas
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Non-Opioid Pain Treatment Market Revenue Growth Supported By A CAGR Of 84.35% Through 2030
The market for non-opioid pain treatments has experienced robust expansion over recent years. Valued at $55.31 billion in 2025, it is projected to reach $60.32 billion by 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. This historical growth has been driven by a rising incidence of chronic pain conditions, greater public awareness of the dangers linked to opioid use, a constrained supply of non-opioid options, an uptick in orthopedic and musculoskeletal surgeries, and the development of enhanced hospital and clinic facilities dedicated to pain management.
The global non-opioid pain treatment market is projected to experience robust expansion over the coming years, reaching an estimated value of $84.36 billion by 2030 at a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is driven by factors such as the emergence of novel non-opioid therapeutic options, the broader implementation of digital health monitoring and telemedicine solutions for pain management, a rising preference for combination treatment approaches, enhanced governmental support for pain relief initiatives, and greater funding directed toward personalized pain care and alternative therapies. Key developments shaping the market landscape include a growing shift toward non-opioid pain management strategies, heightened utilization of medical cannabis and omega-3 fatty acid supplements, an expanding range of topical and injectable pain relief offerings, the proliferation of dedicated pain management services in clinical and hospital settings, and the incorporation of non-pharmacological methods such as acupuncture and transcutaneous electrical nerve stimulation (TENS) into standard care protocols.
Download A Free Sample Report For Comprehensive Market Insights:
#Non-Opioid Pain Treatment Market Growth Factors: Which Forces Are Supporting Market Expansion?
The projected expansion of the non-opioid pain treatment market is anticipated to be driven forward by the growing frequency of sports-related injuries. These injuries are physical harms that happen during or due to participation in sports or exercise. This upsurge is linked to a higher involvement in demanding athletic and recreational pursuits, which puts athletes at an increased danger of physical harm. Managing such injuries benefits from non-opioid pain therapies, which deliver efficient pain alleviation and decreased inflammation while avoiding the dangers tied to opioid usage, thereby promoting quicker recovery, enhanced functionality, and safer extended care. As an example, in October 2024, a report from Howden Group Holdings Ltd, a UK-based insurance intermediary firm, indicated that Europe’s five primary football leagues recorded 4,123 injuries during the 2023-2024 season, representing a 4% rise from the prior season. Consequently, the heightened occurrence of sports-related injuries is fueling growth in the non-opioid pain treatment market.
Non-Opioid Pain Treatment Market Segment Breakdown: Which Categories Generate The Most Revenue?
The non-opioid pain treatment market covered in this report is segmented –
1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products
2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes
3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies
5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications
Subsegments:
1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products
2) By Menthol Containing: Topical Creams, Gels, Sprays
3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements
4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A
5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays
6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices
Non-Opioid Pain Treatment Market Industry Trends: What Changes Are Reshaping Demand?
Major players in the non-opioid pain treatment industry are concentrating on advances in drug development, including non-opioid oral therapies that offer effective pain relief while reducing the dangers associated with opioid use and addiction. Non-opioid oral treatment involves pain-relieving medications taken by mouth that exclude opioids and work through different pathways, like decreasing inflammation, altering nerve signaling, or targeting certain receptors, to control pain without the risk of addiction or respiratory depression typically connected to opioids. For example, in July 2025, Vertex Pharmaceuticals Incorporated, a biotechnology firm based in the United States, launched JOURNAVX, a pioneering non-opioid therapy that delivers significant relief for moderate-to-severe acute pain. This innovative non-opioid solution uses targeted pain pathway modulation, boasts a positive safety profile, and provides fast-acting effects, ensuring robust pain control, lower addictive potential, and improved patient outcomes. It guarantees precise pain management, diminishes addiction risks, and promotes quicker recovery and an enhanced quality of life for individuals dealing with acute pain.
Non-Opioid Pain Treatment Market Key Players And Strategic Industry Positioning
Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA
Access The Complete Non-Opioid Pain Treatment Market Report:
Non-Opioid Pain Treatment Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
